Booster vaccination with hexavalent DTPa-HBV-IPV/Hib vaccine in the second year of life is as safe as concomitant DTPa-IPV/Hib + HBV administered separately

Vaccine

Volumn 23, Issue 9, 2005, Pages 1135-1143

  Saenger, R ^a   Maechler, G ^a   Potreck, M ^a   Zepp, F ^b   Knuf, M ^b   Habermehl, P ^b   Schuerman, L ^c  

^a GLAXOSMITHKLINE   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Booster dose; Combination paediatric vaccines; DTPa; Hexavalent DTPa HBV IPV Hib vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ENGERIX; HEPATITIS B VACCINE;

ANOREXIA; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DROWSINESS; DRUG SAFETY; EDEMA; FEBRILE CONVULSION; FEVER; HUMAN; INFANT; IRRITABILITY; MULTICENTER STUDY; PAIN; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

CONFIDENCE INTERVALS; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; FEVER; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INFANT; MALE; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; VACCINES, COMBINED;

EID: 11244253760     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.08.030     Document Type: Article

References (37)

1. C. Capiau, J. Poolman, B. Hoet, H. Bogaerts, and F. Andre Development and clinical testing of multivalent vaccines based on a diphtheria-tetanus- acellular pertussis vaccine: difficulties encountered and lessons learned Vaccine 21 2003 2273 2287
2. Combination vaccines for childhood immunization. MMWR Recomm Rep 1999;48(RR-5):1-14
3. M.D. Decker, K.M. Edwards, and M.C. Steinhoff Comparison of 13 acellular pertussis vaccines: adverse reactions Pediatrics 96 3 Pt 2 1995 557 566
4. T. Jefferson, M. Rudin, and C. DiPietrantonj Systematic review of the effects of pertussis vaccines in children Vaccine 21 2003 2003 2014
5. Prevention of poliomyelitis: recommendations for use of only inactivated poliovirus vaccine for routine immunization. Committee on Infectious Diseases. American Academy of Pediatrics. Pediatrics 1999;104(6):1404-6.
6. P. Van Damme Hepatitis B: vaccination programmes in Europe - an update Vaccine 19 17-19 2001 2375 2379
7. Global Programme for Vaccines and Immunization (GPV). The WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec 1998;73(10):64-8.
8. H. Helwig, J. Mertsola, D. Harvey, D. Nicolopoulos, J.-C. Schaack, and W. Sedlak Childhood immunisation in the European Union Eur J Pediatr 157 1998 676 680
9. F. Zepp, A. Schuind, C. Meyer, R. Sanger, A. Kaufhold, and P. Willems Safety and reactogenicity of a novel DTPa-HBV-IPV combined vaccine given along with commercial Hib vaccines in comparison with separate concomitant administration of DTPa, Hib, and OPV vaccines in infants Pediatrics 109 4 2002 e58
10. R. Gylca, V. Gylca, and O. Benes A new DTPa-HBV-IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth Vaccine. 19 7-8 2000 825 833
11. S.H. Yeh, J.I. Ward, and S. Partridge Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants Pediatr Infect Dis J 20 10 2001 973 980
12. R. Dagan, K. Igbaria, L. Piglansky, R. Melamed, P. Willems, and A. Grossi Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine Pediatr Infect Dis J 16 1997 1113 1121
13. S. Halperin, J. King, B. Law, E. Mills, and P. Willems Safety and Immunogenicity of Haemophilus influenzae - tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses Clin Infect Dis 28 1999 995 1001
14. Schmitt HJ. Pneumococcal conjugate vaccines in Europe, Berlin, Germany, 23-25 August 2000. Report of a European Advisory Board meeting. Vaccine 2001;19:3347-54.
15. S.L. Morley, and A.J. Pollard Vaccine prevention of meningococcal disease, coming soon? Vaccine 20 5-6 2001 666 687
16. M.P. Curran, and K.L. Goa DTPa-HBV-IPV/Hib vaccine (Infanrix hexa) Drugs 63 7 2003 673 682
17. H.J. Schmitt, M. Knuf, E. Ortiz, R. Sanger, M.C. Uwamwezi, and A. Kaufhold Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus - inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections J Pediatr 137 3 2000 304 312
18. H. Bogaerts Protection against six childhood diseases with a hexavalent vaccine An Esp Pediatr 57 Suppl 3 2002 41 46
19. J. Aristegui, R. Dal-Ré, J.D. Diez-Delgado, J. Marés, J.M. Casanovas, and P. Garcia-Corbeira Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2,4 and 6 months of age Vaccine 21 2003 3593 3600
20. F. Zepp, M. Knuf, U. Heininger, K. Jahn, A. Collard, and P. Habermehl Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants Vaccine 22 2004 2226 2233
21. M. Gubser, A. Blumberg, and F. Donati Febrile convulsions: assessment of current status Schweiz Med Wochenschr. 129 17 1999 649 657
22. S.F. Al Ajlouni, and I.H. Kodah Febrile convulsions in children Saudi Med J 21 7 2000 617 621
23. H.J. Schmitt, K. Beutel, and A. Schuind Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age J Pediatr 130 4 1997 616 623
24. E. Miller, M. Rush, and LA.E. Ashworth Antibody responses and reactions to the whole cell pertussis component of a combined diphtheria/tetanus/pertussis vaccine given at school entry Vaccine 13 13 1995 1183 1186
25. G.R. Noble, R.H. Bernier, and E.C. Esber Acellular and whole-cell pertussis vaccines in Japan, Report of a visit by US scientists JAMA 257 10 1987 1351 1356
26. E.J. Woo, D.R. Burwen, S.N. Gatumu, and R. Ball Extensive limb swelling after immunization: reports to the vaccine adverse event reporting system Clin Infect Dis 37 2003 351 358
27. T.J. Santner, and M.K. Snell Small-sample confidence intervals for p1-p2 and p1/p2 in 2 × 2 contingency tables JAMA 75 1980 386 394
28. N.A. Halsey Safety of combination vaccines: perception versus reality J Pediatr Infect Dis 20 11 2001 S40 S44
29. H.J. Schmitt, F. Zepp, and S. Muschenborn Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations Eur J Pediatr 157 3 1998 208 214
30. M.E. Pichichero, M.A. Deloria, and M.B. Rennels A Safety and immunogenicity comparison of 12 acellular pertussis vaccines with one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children Pediatrics 100 1997 772 788
31. C.L. Cody, L.J. Baraff, J.D. Cherry, S.M. Marcy, and C.R. Manclark Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children Pediatrics 68 1981 650 660
32. D.G. Hirtz Generalized tonic-clonic and febrile seizures Pediatr Clin North Am 36 2 1989 365 382
33. W.E. Barlow, R.L. Davis, and J.W. Glasser The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine N Engl J Med 345 2001 656 661
34. L.A. Jackson, B.A. Carste, D. Malais, and J. Froeschle Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids Pediatr Infect Dis J 21 8 2002 781 786
35. M.B. Rennels, M.A. Deloria, and M.E. Pichichero Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines Pediatrics 105 1 2000 e12
36. M.B. Rennels Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines Semin Pediatr Infect Dis 14 3 2003 196 198
37. D.W. Scheifele, S.A. Halperin, and A.C. Ferguson Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens Vaccine 19 32 2001 4720 4726